会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors
    • 用作HSP90抑制剂的吡咯并嘧啶衍生物
    • US20090163490A1
    • 2009-06-25
    • US12282526
    • 2007-03-09
    • Paul Andrew BroughMartin James DrysdaleNicholas Gareth DaviesNicolas Noel FoloppeStephen Stokes
    • Paul Andrew BroughMartin James DrysdaleNicholas Gareth DaviesNicolas Noel FoloppeStephen Stokes
    • A61K31/5377C07D487/04A61P31/12A61K31/519
    • C07D487/04
    • Compounds of formula (I) have HSP90 inhibitory activity and are therefore useful in the treatment of, inter alia, cancer: Formula (I) wherein Ri is hydrogen, fluoro, chloro, bromo, or a radical of formula -X-Alk1-(Z)m-(Alk2)n-Q wherein X is —O—, —S— —S(O)—, SO2—, or —NH—, Z is —O—, —S—, —(C═O)—, —(C═S)—, —S(O)—, —SO2—, —NRA—, or, in either orientation —C(═O)O—, —C(═O)NRA—, —C(═S)NRA—, —SO2NRA—, —NRAC(═O)—, or —NRASO2— wherein RA is hydrogen or C1-C6 alkyl AIk1 and AIk2 are optionally substituted divalent C1-C3 alkylene or C2-C3 alkenylene radicals, m, n and p are independently 0 or 1, and Q is hydrogen or an optionally substituted carbocyclic or heterocyclic radical; R2 is a radical of formula —(Ar1)p-(Alk1)q-(Z)r-(Alk2)s-Q wherein Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1, Alk2, Z, and Q are as defined above, and p, q, r and s are independently 0 or 1; and R3 is cyano (—CN), fluoro, chloro, bromo, methyl in which in which one or more hydrogen atoms are optionally replaced by fluorine atoms, ethyl in which in which one or more hydrogen atoms are optionally replaced by fluorine atoms, cyclopropyl, —OH, —CH2OH, —C(O)NH2, —C(O)CH3, Or —NH2.
    • 式(I)化合物具有HSP90抑制活性,因此可用于治疗尤其是癌症:式(I)其中R 1是氢,氟,氯,溴或式-X-Alk1-( Z)m-(Alk2)nQ其中X是-O - , - S-S(O) - ,SO2-或-NH-,Z是-O - , - S-, -​​ (CO) ( - ) - , - ( - O - ) - , - ( - O - ) - , - ( - - , - SO 2 -NRA - , - NRAC(-O) - 或-NRASO 2 - ,其中RA为氢或C 1 -C 6烷基,Alk 1和Alk 2为任选取代的二价C 1 -C 3亚烷基或C 2 -C 3亚烯基,m,n和p 独立地为0或1,并且Q为氢或任选取代的碳环或杂环基; R2是式 - (Ar1)p-(Alk1)q-(Z)r-(Alk2)sQ的基团,其中Ar1是任选取代的芳基或杂芳基,Alk1,Alk2,Z和Q如上定义, 和p,q,r和s独立地为0或1; 并且R 3是氰基(-CN),氟,氯,溴,其中一个或多个氢原子任选被氟原子取代的甲基,其中一个或多个氢原子任选被氟原子取代的乙基,环丙基 ,-OH,-CH 2 OH,-C(O)NH 2,-C(O)CH 3或-NH 2。
    • 2. 发明授权
    • Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
    • 具有检查点激酶1抑制活性的吲哚基 - 吡啶酮衍生物
    • US08916591B2
    • 2014-12-23
    • US12812791
    • 2009-01-20
    • Stephen StokesNicolas FoloppeAndrea FiumanaMartin DrysdaleSimon BedfordPaul Webb
    • Stephen StokesNicolas FoloppeAndrea FiumanaMartin DrysdaleSimon BedfordPaul Webb
    • A61K31/4439C07D401/14
    • C07D401/14A61K31/4439A61K31/4545A61K31/496A61K31/5377C07D413/14
    • Compounds of formula (I) have checkpoint kinase 1 (CHK1) inhibitory activity: wherein R1, R2, R5 and R6 are independently selected from hydrogen, hydroxy, methyl, trifluoromethyl, hydroxymethyl, methoxy, trifluoromethoxy, methylamino and dimethylamino; R3, and R4 are independently selected from hydrogen, hydroxy, C1-C3 alkyl, fluoro-(C1-C3)-alkyl, hydroxy-(C1C3)-alkyl, C1-C3 alkoxy, fluoro-(C1-C3)-alkoxy, hydroxy-(C1-C3)-alkoxy, -AIk-N(R11)—R12, -0-AIk-N(R11)—R12, —C(═O)OH, carboxy-(C1-C3)-alkyl, or —C(═O)—NH—R13; AIk is a straight or branched chain divalent C1-C6 alkylene radical; R7 and R8 are independently selected from hydrogen, hydroxy, or C1-C3 alkoxy; X is a straight chain divalent C1-C3 alkylene radical, optionally substituted on one or more carbons by R9 and/or R10; W is selected from —C(═O)—N(—R16)— or —N(—R17)—C(═O)—; Y is hydrogen, C1-C3 alkyl, C1-C3 alkoxy, or halo; and Q is selected from optionally substituted phenyl, optionally substituted cyclohexyl, or an optionally substituted 6-membered monocyclic heteroaryl ring.
    • 式(I)化合物具有检测点激酶1(CHK1)抑制活性:其中R1,R2,R5和R6独立地选自氢,羟基,甲基,三氟甲基,羟甲基,甲氧基,三氟甲氧基,甲基氨基和二甲基氨基; R 3和R 4独立地选自氢,羟基,C 1 -C 3烷基,氟 - (C 1 -C 3) - 烷基,羟基 - (C 1 -C 3) - 烷基,C 1 -C 3烷氧基,氟 - (C 1 -C 3) - 烷氧基, 羟基 - (C1-C3) - 烷氧基,-Ik-N(R11)-R12,-O-Alk-N(R11)-R12,-C(= O)OH,羧基 - (C1-C3) - 烷基, 或-C(= O)-NH-R 13; Alk是直链或支链二价C1-C6亚烷基; R 7和R 8独立地选自氢,羟基或C 1 -C 3烷氧基; X是直链的二价C1-C3亚烷基,任选地被一个或多个碳上被R9和/或R10取代; W选自-C(= O)-N(-R 16) - 或-N(-R 17)-C(= O) - ; Y是氢,C 1 -C 3烷基,C 1 -C 3烷氧基或卤素; 并且Q选自任选取代的苯基,任选取代的环己基或任选取代的6元单环杂芳基环。
    • 5. 发明申请
    • INDOLYL- PYRIDONE DERIVATIVES HAVING CHECKPOINT KINASE 1 INHIBITORY ACTIVITY
    • 具有检测点激酶1的吲哚基 - 吡啶酮衍生物1抑制活性
    • US20110021498A1
    • 2011-01-27
    • US12812791
    • 2009-01-20
    • Stephen StokesNicolas FoloppeAndrea FiumanaMartin DrysdaleSimon BedfordPaul Webb
    • Stephen StokesNicolas FoloppeAndrea FiumanaMartin DrysdaleSimon BedfordPaul Webb
    • A61K31/397A61P35/00A61P19/02C07D401/14A61K31/4439A61K31/444A61K31/4545C07D413/14A61K31/5377
    • C07D401/14A61K31/4439A61K31/4545A61K31/496A61K31/5377C07D413/14
    • Compounds of formula (I) have checkpoint kinase 1 (CHK1) inhibitory activity: wherein R1, R2, R5 and R6 are independently selected from hydrogen, hydroxy, methyl, trifluoromethyl, hydroxymethyl, methoxy, trifluoromethoxy, methylamino and dimethylamino; R3, and R4 are independently selected from hydrogen, hydroxy, C1-C3 alkyl, fluoro-(C1-C3)-alkyl, hydroxy-(C1C3)-alkyl, C1-C3 alkoxy, fluoro-(C1-C3)-alkoxy, hydroxy-(C1-C3)-alkoxy, -AIk-N(R11)—R12, -0-AIk-N(R11)—R12, —C(═O)OH, carboxy-(C1-C3)-alkyl, or —C(═O)—NH—R13; AIk is a straight or branched chain divalent C1-C6 alkylene radical; R7 and R8 are independently selected from hydrogen, hydroxy, or C1-C3 alkoxy; X is a straight chain divalent C1-C3 alkylene radical, optionally substituted on one or more carbons by R9 and/or R10; W is selected from —C(═O)—N(—R16)— or —N(—R17)—C(═O)—; Y is hydrogen, C1-C3 alkyl, C1-C3 alkoxy, or halo; and Q is selected from optionally substituted phenyl, optionally substituted cyclohexyl, or an optionally substituted 6-membered monocyclic heteroaryl ring.
    • 式(I)化合物具有检测点激酶1(CHK1)抑制活性:其中R1,R2,R5和R6独立地选自氢,羟基,甲基,三氟甲基,羟甲基,甲氧基,三氟甲氧基,甲基氨基和二甲基氨基; R 3和R 4独立地选自氢,羟基,C 1 -C 3烷基,氟 - (C 1 -C 3) - 烷基,羟基 - (C 1 -C 3) - 烷基,C 1 -C 3烷氧基,氟 - (C 1 -C 3) - 烷氧基, 羟基 - (C1-C3) - 烷氧基,-Ik-N(R11)-R12,-O-Alk-N(R11)-R12,-C(= O)OH,羧基 - (C1-C3) - 烷基, 或-C(= O)-NH-R 13; Alk是直链或支链二价C1-C6亚烷基; R 7和R 8独立地选自氢,羟基或C 1 -C 3烷氧基; X是直链的二价C1-C3亚烷基,任选地被一个或多个碳上被R9和/或R10取代; W选自-C(= O)-N(-R 16) - 或-N(-R 17)-C(= O) - ; Y是氢,C 1 -C 3烷基,C 1 -C 3烷氧基或卤素; 并且Q选自任选取代的苯基,任选取代的环己基或任选取代的6元单环杂芳基环。
    • 6. 发明申请
    • Locatable dielectric optical fiber cable having easily removable locating element
    • 具有易拆卸定位元件的可定位电介质光缆
    • US20080080820A1
    • 2008-04-03
    • US11980959
    • 2007-10-31
    • Robert AndrewsScott ChastainStephen StokesGeorge Mackie
    • Robert AndrewsScott ChastainStephen StokesGeorge Mackie
    • H01B11/22G02B6/44
    • G02B6/447G02B6/4495
    • An optical fiber cable having a locating element and extending from a distribution enclosure to a premise is provided. The optic fiber cable includes a core having at least one optical fiber transmission medium disposed within a tubular member that has a jacket system disposed thereabout. A longitudinally extending detectable element is provided that does not function as a communications cable and that is detachably connected to said tubular member by the jacket system which is also disposed about the detectable element so as to define a web between the tubular member and the detectable element. The detectable element terminates before at least one of the distribution enclosure or the premise. The web defines a notch between the tubular member and the detectable element which serves as a shear plane to facilitate the propagation of a tear between the tubular member and the detectable element.
    • 提供了一种具有定位元件并从分配机壳延伸到前提的光缆。 光纤电缆包括具有至少一个光纤传输介质的芯体,该光纤传输介质设置在管状部件内,该管状部件具有设置在其周围的护套系统。 提供了一种纵向延伸的可检测元件,其不用作通信电缆,并且通过护套系统可拆卸地连接到所述管状构件,护套系统也围绕可检测元件设置,以便在管状构件和可检测元件之间限定腹板 。 可检测元件在分配封壳或前提中的至少一个之前终止。 网状物在管状构件和可检测元件之间限定了一个凹口,其用作剪切平面以便于在管状构件和可检测元件之间传播泪液。